Delivery Order SPE2DB22D3016-SPE2DB25FBGS1
Award Date 8/29/25
Potential Completion Date 9/22/25
Potential Value $43K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of TAGRISSO 40 mg tablets (30-count packages) valued at $31,923.21. This firm fixed-price delivery order, issued on August 27, 2025, with completion scheduled for September 18, 2025, represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at...
- The Defense Logistics Agency awarded a delivery order valued at $10,662.57 to AmerisourceBergen Drug Corp for TAGRISSO 80 mg tablets (30-count units) on August 19, 2025, with completion targeted for September 10, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procedures. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and serves as a critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a $21,282.14 delivery order to AmerisourceBergen Drug Corp for TAGRISSO 40 mg tablets (30-count units) on August 19, 2025, with an ultimate completion date of September 10, 2025. This non-set-aside, firm fixed-price contract represents a delivery order under the company's larger indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for TAGRISSO 40 mg tablets (30-count units) valued at $10,641.07 under a firm fixed-price contract type. The contract, issued on August 22, 2025, with an ultimate completion date of September 15, 2025, represents a non-competitive delivery against the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of TAGRISSO 80 mg tablets (30-count units) under a firm fixed-price contract with a ceiling value of $127,093.14. The delivery order, awarded on August 27, 2025, is scheduled for ultimate completion by September 18, 2025. This is a competitive award with no set-aside designation, and performance will be executed from AmerisourceBergen's Conshohocken, Pennsylvania...
- The Defense Logistics Agency awarded a delivery order valued at $10,641.07 to AmerisourceBergen Drug Corp for the supply of TAGRISSO 40 mg tablets (30-count units) under a firm fixed price contract. This delivery order, issued on July 30, 2025, with an ultimate completion date of August 20, 2025, represents a non-set-aside, competitively awarded procurement. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. TAGRISSO is a prescription...
- The Defense Logistics Agency awarded a $10,662.57 firm fixed price delivery order to AmerisourceBergen Drug Corp for TAGRISSO 80 mg tablets (30-count packages) on August 11, 2025, with an ultimate completion date of September 2, 2025. This non-set-aside contract represents a competitive award for pharmaceutical supply to support federal medical procurement needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for the Defense Logistics Agency's Medical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $21,325.14 for TAGRISSO 80 mg tablets (30-count units) on July 31, 2025, with an ultimate completion date of August 21, 2025. This firm fixed-price, competitively awarded delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. TAGRISSO is a prescription oncology medication used primarily in the treatment of...
- The Defense Logistics Agency awarded a delivery order valued at $10,641.07 to AmerisourceBergen Drug Corp for the supply of TAGRISSO 40 mg tablets (30-count packages). This firm fixed price contract, issued on August 12, 2025, with an ultimate completion date of September 3, 2025, represents a direct fulfillment of pharmaceutical needs within the federal medical supply chain. The award was competitively procured with no set-aside designation, reflecting AmerisourceBergen's demonstrated...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for TAGRISSO 80 mg tablets (30-count supply) valued at approximately $53.3K. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of August 14, 2025, awarded on July 24, 2025. The pharmaceutical product will be supplied to the federal government through AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the company's...